Bone health

Zoledronic acid finds new role in leukaemia

The anti-resorptive drug zoledronic acid used in osteoporosis, may have potential in the treatment of leukaemia in children, researchers in WA have shown. Dr Laurence Cheung and co-researchers at the Telethon Kids Cancer Centre in Perth say they have identified the mechanism of bone loss that occurs during the development of leukaemia – which, when ...

Already a member?

Login to keep reading.

© 2021 the limbic